Amanta Healthcare Limited is a pharmaceutical manufacturer engaged in developing, producing, and marketing a diverse range of sterile liquid products, including large and small volume parenterals (LVPs and SVPs), supported by Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. Its portfolio covers 6 therapeutic areas such as fluid therapy, formulations, diluents, ophthalmic, respiratory care, and irrigation solutions, alongside medical devices like irrigation and first-aid solutions, and eye lubricants. The co. operates multiple GMP-certified manufacturing lines for both LVPs and SVPs. With cGMP compliance and WHO-recommended certifications, it serves domestic and international markets across segments including antibiotics, antifungals, diuretics, and respiratory care.
Price Band₹120 - ₹126 |
Dates01 Sep - 03 Sep |
GMP₹9 (7.14%) |
Subscriptions82.61 times |
Issue Size₹126.00 Crs |
Price Band₹120 - ₹126 |
Listing AtNSE & BSE |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹126.00 Cr (1.00 Cr Shares) |
Offer For Sale₹0.00 (0.00 Shares) |
Total Issue₹126.00 Cr (1.00 Cr Shares) |
Face Value₹10 per equity share |
Investor Category | Lot | Shares | Amount | |
---|---|---|---|---|
Retail |
Minimum
1
119
14,994
Maximum
13
1,547
1,94,922
|
|||
Small HNI |
Minimum
14
1,666
2,09,916
Maximum
66
7,854
9,89,604
|
|||
Big HNI |
Minimum
67
7,973
10,04,598
|
Updated as on 03-Sep-2025 19:00:00
Investor Category | Subscription (times) | Shares Offered | Shared Bid |
---|---|---|---|
QIB | 35.86 | 20,00,000 | 7,17,22,490 |
NII | 209.42 | 15,00,000 | 31,41,35,486 |
bNII (bids above ₹10L) | 226.13 | 10,00,000 | 22,61,27,251 |
sNII (bids between ₹2L to ₹10L) | 176.02 | 5,00,000 | 8,80,08,235 |
Retail | 54.98 | 35,00,000 | 19,24,22,762 |
Total | 82.61 | 70,00,000 | 57,82,80,738 |
The estimated Grey Market Premium of Amanta Healthcare IPO is ₹9 per share (7.14%)
Particulars | Allocation |
---|---|
QIBs | Not more than 50% of Net Offer |
Big HNIs (NII) | Not less than 10% of Net Offer |
Small HNIs (NII) | Not less than 5% of Net Offer |
Retail | Not less than 35% of Net Offer |
Particulars | Mar-25 | Mar-24 | Mar-23 |
---|---|---|---|
Revenue from Operations | 274.71 | 280.34 | 259.13 |
Profit after Tax | 10.50 | 3.63 | -2.11 |
Net Worth | 96.39 | 66.29 | 62.88 |
Total Borrowing | 195.00 | 205.23 | 215.66 |
Total Assets | 381.76 | 352.12 | 374.06 |
NAV per share (in ₹) | 33.43 | 24.71 | 23.44 |
EPS - Basic (in ₹) | 3.71 | 1.35 | -0.79 |
The financial information presented is on a consolidated basis.
KPI | Values |
---|---|
EBITDA | 22.11% |
PAT | 3.86% |
ROE | 12.42% |
ROCE | 13.72% |
Debt to Equity | 2.02 |
PE Ratio | 33.96 |
PB Ratio | 3.77 |
Mkt Cap (in Crs.) | 489.25 |
Particulars | Amanta Healthcare | Denis Chem Lab |
---|---|---|
Revenue from Ops (in Crs.) | 274.71 | 173.30 |
PAT (In Crs.) | 10.50 | 8.08 |
EPS - Basic | 3.71 | 5.82 |
NAV per share | 33.43 | 61.33 |
RONW | 10.89% | 9.49% |
EBITDA | 22.11% | 10.52% |
PAT Margin | 3.86% | 4.66% |
Price to earning (PE) | 33.96 | 15.92 |
Debt to Equity | 2.02 | 0.01 |
Particulars | Amanta Healthcare |
---|---|
Revenue from Ops (in Crs.) | 274.71 |
PAT (In Crs.) | 10.50 |
EPS - Basic | 3.71 |
NAV per share | 33.43 |
RONW | 10.89% |
EBITDA | 22.11% |
PAT Margin | 3.86% |
Price to earning (PE) | 33.96 |
Debt to Equity | 2.02 |
Denis Chem Lab |
---|
173.30 |
8.08 |
5.82 |
61.33 |
9.49% |
10.52% |
4.66% |
15.92 |
0.01 |
Name | Shareholding |
---|---|
Bhavesh Patel | 21.68% |
Vishal Patel | 13.55% |
Jitendrakumar Patel | 12.09% |
Others | 38.28% |
Total | 85.60% |
Name | Designation |
---|---|
Bhavesh Patel | Chairman & MD |
Shailesh Shah | CFO |
Name: Amanta Healthcare Limited
Address: 8th Floor, Shaligram Corporates, C.J. Marg, Ambli, Ahmedabad – 380058, Gujarat India
Number: 079 67777600
Email: cs@amanta.co.in
Website: www.amanta.co.in
Find answers to common questions that come in your mind related to IPO.
Amanta Healthcare IPO is a Mainboard IPO having an issue size of Rs. ₹126.00 Crs. Amanta Healthcare IPO is priced at ₹120 - ₹126 per share. The issue opens on 01 Sep 25 and closes on 03 Sep 25.
Amanta Healthcare IPO opens on 01 Sep 25 and closes on 03 Sep 25.
The estimated Grey Market Premium of Amanta Healthcare IPO is ₹9 per share (7.14%).
The minimum lot size of Amanta Healthcare IPO is 119 shares & the minimum application amount is Rs. 14994.
The allotment date of Amanta Healthcare IPO is 04 Sep 25.
The listing date of Amanta Healthcare IPO is 09 Sep 25.
Amanta Healthcare IPO is subscribed 82.61 times.
Amanta Healthcare IPO is priced at ₹120 - ₹126 per share.
Click the allotment link on Amanta Healthcare IPO page of IPO360.